{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:52:02Z","timestamp":1762977122088,"version":"3.45.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xpro.2020.100264","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T18:16:31Z","timestamp":1610648191000},"page":"100264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An optimized protocol for the generation of HBV viral antigen-specific T lymphocytes from pluripotent stem cells"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-0595","authenticated-orcid":false,"given":"Mohammad","family":"Haque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-8314","authenticated-orcid":false,"given":"Fengyang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugal Kishore","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-6176","authenticated-orcid":false,"given":"Jianxun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2020.100264_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8(+) T\u00a0cells undergoing hepatic priming","volume":"574","author":"Benechet","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2020.100264_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jhep.2016.07.011","article-title":"Determinants of hepatic effector CD8(+) T\u00a0cell dynamics","volume":"66","author":"Benechet","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xpro.2020.100264_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2010.10.025","article-title":"Engineering virus-specific T\u00a0cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines","volume":"55","author":"Gehring","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xpro.2020.100264_bib9","doi-asserted-by":"crossref","first-page":"101333","DOI":"10.1016\/j.isci.2020.101333","article-title":"Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-\u03b3 and TNF-\u237a","volume":"23","author":"Haque","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2020.100264_bib4","doi-asserted-by":"crossref","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues\u00a0antiviral CD8(+) T\u00a0cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xpro.2020.100264_bib5","doi-asserted-by":"crossref","first-page":"e01099-18","DOI":"10.1128\/JVI.01099-18","article-title":"Type I interferon signaling prevents hepatitis B virus-specific T\u00a0cell responses by reducing antigen expression","volume":"92","author":"Kawashima","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xpro.2020.100264_bib6","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/0008-5472.CAN-11-0359","article-title":"In\u00a0vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance","volume":"71","author":"Lei","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.xpro.2020.100264_bib7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In\u00a0vitro-expanded antigen-specific regulatory T\u00a0cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xpro.2020.100264_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166720302513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166720302513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:48:11Z","timestamp":1762976891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166720302513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666166720302513"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2020.100264","relation":{},"ISSN":["2666-1667"],"issn-type":[{"type":"print","value":"2666-1667"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized protocol for the generation of HBV viral antigen-specific T lymphocytes from pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2020.100264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2020.101333","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100264"}}